Marshall Edwards Inc.

Press Releases

2004-June-14	Marshall Edwards, Inc., Names Second Study Site in Multi-National Ovarian Cancer Trial of Investigational Anti-Cancer Drug Phenoxodiol (in PDF)
2004-May-17	The University of Sydney Honors Marshall Edwards Inc Chairman. (in PDF)
2004-April-22	New Trial to Evaluate Phenoxodiol as Chemo-Sensitizing Agent in Patients with Chemo-Resistant Ovarian Cancer (in PDF)
2004-March-31	Investigational Anti-Cancer Drug Phenoxodiol Produces Response and Restores Chemo-Sensitivity in Four Studies (in PDF)
2004-March-26	Late Breaking Clinical Trial Results of Investigational Anti-Cancer Drug Phenoxodiol among Four Abstracts to be Presented at the American Association for Cancer Research Annual Meeting (in PDF)
2004-March-9	Marshall Edwards, Inc. Commences Renal Cancer Human Trial of Phenoxodiol in Combination Therapy (in PDF)
2004-February-23	Marshall Edwards, Inc. Commences Clinical Trial in Cervical Cancer at Yale (in PDF)
2004-February-9	Study at Yale University Supports Development of Phenoxodiol as a Drug to Restore Chemo-sensitivity in Non-responsive Women (in PDF)
2003	2003 Press Releases
2002	2002 Press Releases